RISA Labs, a Palo Alto, California–based AI operating system for oncology, has raised $11.1 million in Series A funding.
Investors
The round was co-led by Cencora Ventures and Optum Ventures, with participation from Oncology Ventures, Z21 Ventures, and John Simon via Ventureforgood.
Cencora Ventures is the corporate venture capital arm of Cencora, a global pharmaceutical solutions organization dedicated to improving the health of people and animals worldwide. By partnering with innovators across the pharmaceutical value chain, Cencora facilitates market access to therapies while ensuring the secure and reliable delivery of pharmaceuticals, healthcare products, and solutions.
RISA Labs Use of Funds
The company will use the funding to expand deployment of its AI operating system across cancer clinics, health systems, specialty pharmacies, and infusion networks, while enhancing its platform capabilities.
About RISA Labs
Founded by Kshitij Jaggi and Kumar Shivang, RISA Labs is the creator of BOSS Console, which helps build AI OS for mission-critical institutions. Its AI-driven operating system automates complex administrative workflows such as patient access, benefits verification, and prior authorizations. The platform allows mission-critical institutions to tailor workflows, routing, document conventions, and practice-specific rules. By connecting to EMRs, payer systems, and other records, RISA’s AI agents adapt in real time to changing forms, rules, and interfaces.
Funding Details
Company: RISA Labs
Raised: $11.1M
Round: Series A
Funding Date: January 2026
Lead Investors: Cencora Ventures, Optum Ventures
Additional Investors: Oncology Ventures, Z21 Ventures, John Simon (Ventureforgood)
Company Website: https://www.risalabs.ai/
Software Category: HealthTech / AI Operating System for Oncology
Source: https://www.prnewswire.com/news-releases/risa-labs-closes-11-1m-series-a-to-scale-ai-operating-system-for-oncology-nationwide-302659644.html